Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Drawbridge Health has developed proprietary blood collection devices such as OneDraw™ and NanoDrop that enable simple, comfortable, and convenient blood sample collection anytime and anywhere. These devices are designed to broaden access to molecular tests for various diseases by simplifying the process of drawing and stabilizing blood samples. The company’s technologies have received FDA clearance for over-the-counter use. They are being integrated into at-home testing kits by Thorne. No clinical drug results as the company does not develop therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Drawbridge Health.